Results 41 to 50 of about 699,211 (296)

Does ursodeoxycholic acid change the proliferation of the colorectal mucosa? A randomized, placebo-controlled study [PDF]

open access: yes, 2003
Background: In animal models ursodeoxycholic acid (UDCA) showed a chemoprotective effect against colon cancer. To explain this, a reduced proliferation of the colorectal mucosal proliferation was suggested.
Burkhard Göke   +13 more
core   +1 more source

From mice to humans—divergent strategies for intestinal homeostasis and regeneration

open access: yesFEBS Letters, EarlyView.
Recent advances such as organoid genome editing, xenotransplantation, imaging, and whole‐genome sequencing have enabled direct studies of human intestinal stem cells (ISCs). These studies reveal species‐specific features, including slower ISC proliferation, distinct injury responses, slower somatic mutation accumulation in humans, and an inverse ...
Keiko Ishikawa   +2 more
wiley   +1 more source

Percentage and characteristics of patients diagnosed with malignant neoplasms of colon, rectum or neuroendocrine colorectal tumours.

open access: yes, 2020
Percentage and characteristics of patients diagnosed with malignant neoplasms of colon, rectum or neuroendocrine colorectal tumours.
Josep Darbà (6428639)   +1 more
core   +1 more source

Structure‐forward targeting of claudins with synthetic binders

open access: yesFEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Survival in older adults with colorectal cancer: a literature review

open access: yesArchivo Médico de Camagüey, 2021
Background: colorectal cancer is the most common malignant neoplasia that can occur in the digestive system. There has been a gradual increase in Latin America, Cuba presents health indicators similar to developed nations, and colorectal cancer is the ...
Belkis Alvarez-Escobar   +3 more
doaj  

Infection and Colorectal Neoplasm

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 2015
Colorectal cancer is a major cause of cancer-related morbidity and mortality. Colorectal cancer is the third most common malignancy and the 4th most common cause of cancer mortality worldwide. A number of infectious agents are considered to be cancer risk factors due to the hypothesis-generating and supportive evidence accumulated to date.
Gontar Alamsyah Siregar   +2 more
openaire   +1 more source

Metastatic niche shaped by host factors influences disseminated cancer cell fate

open access: yesFEBS Letters, EarlyView.
Metastasis is shaped not only by cancer cells but also by the environments they encounter. This review explores how factors such as aging, diet, the microbiome, lifestyle, and environmental exposures remodel organ‐specific niches in the lung, liver, bone, and brain, influencing where metastatic cells survive, remain dormant, or grow, and ultimately ...
Gwennan Delyth Ward   +2 more
wiley   +1 more source

Improving the management of colorectal neoplasms in clinical practice [PDF]

open access: yes, 2023
Colorectal cancer is one of the most frequent cancers in the Western world. Forty-five percent of symptomatic patients have metastatic disease. The overall prevalence of adenoma in an asymptomatic population is 25-30% at the age of 50 years and ...
Leicher, L.W.
core  

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Home - About - Disclaimer - Privacy